{"filing":{"accession_number":"0001193125-26-254615","cik":"0001936258","ticker":"NAMSW","company_name":"NewAmsterdam Pharma Co N.V.","form":"8-K","filing_date":"2026-06-03","report_date":null,"primary_document":"nams-20260602.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526254615/nams-20260602.htm"},"events":[{"id":7135,"run_id":6260,"accession_number":"0001193125-26-254615","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"NewAmsterdam Pharma held its Annual General Meeting on June 2, 2026, at which shareholders voted on nine proposals including adoption of annual accounts, director discharge, auditor appointment, director re-appointments, share issuance authorization, and executive compensation approval.","company_name":"NewAmsterdam Pharma Co N.V.","ticker":"NAMSW","filing_date":"2026-06-03","form":"8-K","submitted_at":null,"items":[{"id":3934,"accession_number":"0001193125-26-254615","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on shareholder approval of the NewAmsterdam Pharma Company N.V. 2026 Employee Stock Purchase Plan (ESPP) at the June 2, 2026 Annual General Meeting. This is a compensatory arrangement for eligible employees permitting them to purchase ordinary shares at a 15% discount via payroll deductions, with up to 1,150,000 shares authorized. The filing explicitly describes the plan's mechanics, purchase periods, and discount structure—hallmarks of an executive compensation disclosure under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:21:45.872511+00:00","company_name":"","ticker":null,"filing_date":""},{"id":3935,"accession_number":"0001193125-26-254615","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from the Annual General Meeting held on June 2, 2026, covering nine proposals including adoption of annual accounts, director discharge, auditor appointment, director re-appointments, share issuance authorization, and executive compensation approval. Item 5.07 explicitly requires disclosure of shareholder vote results, and the detailed tabulation of votes for and against each proposal is the hallmark of this event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:21:45.872511+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3934,"accession_number":"0001193125-26-254615","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on shareholder approval of the NewAmsterdam Pharma Company N.V. 2026 Employee Stock Purchase Plan (ESPP) at the June 2, 2026 Annual General Meeting. This is a compensatory arrangement for eligible employees permitting them to purchase ordinary shares at a 15% discount via payroll deductions, with up to 1,150,000 shares authorized. The filing explicitly describes the plan's mechanics, purchase periods, and discount structure—hallmarks of an executive compensation disclosure under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:21:45.872511+00:00","company_name":"NewAmsterdam Pharma Co N.V.","ticker":"NAMSW","filing_date":"2026-06-03"},{"id":3935,"accession_number":"0001193125-26-254615","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from the Annual General Meeting held on June 2, 2026, covering nine proposals including adoption of annual accounts, director discharge, auditor appointment, director re-appointments, share issuance authorization, and executive compensation approval. Item 5.07 explicitly requires disclosure of shareholder vote results, and the detailed tabulation of votes for and against each proposal is the hallmark of this event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:21:45.872511+00:00","company_name":"NewAmsterdam Pharma Co N.V.","ticker":"NAMSW","filing_date":"2026-06-03"}]}